Myocardial energetics and clinical response to the cardiotonic agent MDL 17043 in advanced heart failure
Authors:
- Jack L. MartinJMJack L. Martin
- Mariell J. LikoffMLMariell J. Likoff
- Joseph S. JanickiJJJoseph S. Janicki
- Warren K. LaskeyWLWarren K. Laskey
- John W. HirshfeldJHJohn W. Hirshfeld
- Karl T. WeberKWKarl T. Weber
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Vasodilator and inotropic therapy for severe chronic heart failure: Passion and skepticismJACC, 1983
- The acute hemodynamic effects of a new agent, MDL 17,043, in the treatment of congestive heart failure.Circulation, 1983
- Pathogenesis and management of congestive heart failure—revisitedAmerican Heart Journal, 1983
- Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure.Circulation, 1982
- Cardiovascular Properties of a New Cardiotonic AgentJournal of Cardiovascular Pharmacology, 1982
- Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study.Circulation, 1982
- Effects of respiratory alkalosis on coronary vascular dynamics and myocardial energetics in patients with coronary artery diseaseAmerican Heart Journal, 1981
- Myocardial oxygen consumption in chronic heart disease: Role of wall stress, hypertrophy and coronary reserveThe American Journal of Cardiology, 1979
- Measurement of Coronary Sinus Blood Flow by Continuous Thermodilution in ManCirculation, 1971
- A comparison of the effects of vasodilator stimuli on peripheral resistance vessels in normal subjects and in patients with congestive heart failureJournal of Clinical Investigation, 1968